Works by Bergsagel, Leif

Results: 65
    1
    2

    Preclinical anti-myeloma activity of EDO-S101, a new bendamustine-derived molecule with added HDACi activity, through potent DNA damage induction and impairment of DNA repair.

    Published in:
    Journal of Hematology & Oncology, 2017, v. 10, p. 1, doi. 10.1186/s13045-017-0495-y
    By:
    • López-Iglesias, Ana-Alicia;
    • Herrero, Ana B.;
    • Chesi, Marta;
    • San-Segundo, Laura;
    • González-Méndez, Lorena;
    • Hernández-García, Susana;
    • Misiewicz-Krzeminska, Irena;
    • Quwaider, Dalia;
    • Martín-Sánchez, Montserrat;
    • Primo, Daniel;
    • Paíno, Teresa;
    • Bergsagel, P. Leif;
    • Mehrling, Thomas;
    • González-Díaz, Marcos;
    • San-Miguel, Jesús F.;
    • Mateos, María-Victoria;
    • Gutiérrez, Norma C.;
    • Garayoa, Mercedes;
    • Ocio, Enrique M.
    Publication type:
    Article
    3

    Risk factors for severe infection and mortality In patients with COVID‐19 in patients with multiple myeloma and AL amyloidosis.

    Published in:
    American Journal of Hematology, 2023, v. 98, n. 1, p. 49, doi. 10.1002/ajh.26762
    By:
    • Ho, Matthew;
    • Zanwar, Saurabh;
    • Buadi, Francis K.;
    • Ailawadhi, Sikander;
    • Larsen, Jeremy;
    • Bergsagel, Leif;
    • Binder, Moritz;
    • Chanan‐Khan, Asher;
    • Dingli, David;
    • Dispenzieri, Angela;
    • Fonseca, Rafael;
    • Gertz, Morie A.;
    • Gonsalves, Wilson;
    • Go, Ronald S.;
    • Hayman, Suzanne;
    • Kapoor, Prashant;
    • Kourelis, Taxiarchis;
    • Lacy, Martha Q.;
    • Leung, Nelson;
    • Lin, Yi
    Publication type:
    Article
    4
    5
    6

    Lenalidomide, cyclophosphamide and dexamethasone (CRd) for newly diagnosed multiple myeloma: Results from a phase 2 trial.

    Published in:
    American Journal of Hematology, 2011, v. 86, n. 8, p. 640, doi. 10.1002/ajh.22053
    By:
    • Kumar, Shaji K.;
    • Lacy, Martha Q.;
    • Hayman, Suzanne R.;
    • Stewart, Keith;
    • Buadi, Francis K.;
    • Allred, Jacob;
    • Laumann, Kristina;
    • Greipp, Philip R.;
    • Lust, John A.;
    • Gertz, Morie A.;
    • Zeldenrust, Steven R.;
    • Bergsagel, P. Leif;
    • Reeder, Craig B.;
    • Witzig, Thomas E.;
    • Fonseca, Rafael;
    • Russell, Stephen J.;
    • Mikhael, Joseph R.;
    • Dingli, David;
    • Rajkumar, S. Vincent;
    • Dispenzieri, Angela
    Publication type:
    Article
    7

    Mode of progression in smoldering multiple myeloma: a study of 406 patients.

    Published in:
    Blood Cancer Journal, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41408-024-00980-5
    By:
    • Abdallah, Nadine H.;
    • Lakshman, Arjun;
    • Kumar, Shaji K.;
    • Cook, Joselle;
    • Binder, Moritz;
    • Kapoor, Prashant;
    • Dispenzieri, Angela;
    • Gertz, Morie A.;
    • Lacy, Martha Q.;
    • Hayman, Suzanne R.;
    • Buadi, Francis K.;
    • Dingli, David;
    • Lin, Yi;
    • Kourelis, Taxiarchis;
    • Warsame, Rahma;
    • Bergsagel, Leif;
    • Rajkumar, S. Vincent
    Publication type:
    Article
    8
    9

    Mass Cytometry reveals unique phenotypic patterns associated with subclonal diversity and outcomes in multiple myeloma.

    Published in:
    Blood Cancer Journal, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41408-023-00851-5
    By:
    • Baughn, Linda B.;
    • Jessen, Erik;
    • Sharma, Neeraj;
    • Tang, Hongwei;
    • Smadbeck, James B.;
    • Long, Mark D.;
    • Pearce, Kathryn;
    • Smith, Matthew;
    • Dasari, Surendra;
    • Sachs, Zohar;
    • Linden, Michael A.;
    • Cook, Joselle;
    • Keith Stewart, A.;
    • Chesi, Marta;
    • Mitra, Amit;
    • Leif Bergsagel, P.;
    • Van Ness, Brian;
    • Kumar, Shaji K.
    Publication type:
    Article
    10

    Prognostic value of early bone marrow MRD status in CAR-T therapy for myeloma.

    Published in:
    Blood Cancer Journal, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41408-023-00820-y
    By:
    • Bansal, Radhika;
    • Baksh, Mizba;
    • Larsen, Jeremy T.;
    • Hathcock, Matthew A.;
    • Dingli, David;
    • Stewart, A. Keith;
    • Kapoor, Prashant;
    • Kourelis, Taxiarchis;
    • Hayman, Suzanne R.;
    • Warsame, Rahma M.;
    • Fonseca, Rafael;
    • Bergsagel, P. Leif;
    • Ailawadhi, Sikander;
    • Kumar, Shaji K.;
    • Lin, Yi
    Publication type:
    Article
    11

    Integrated analysis of next generation sequencing minimal residual disease (MRD) and PET scan in transplant eligible myeloma patients.

    Published in:
    Blood Cancer Journal, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41408-023-00794-x
    By:
    • Fonseca, Rodrigo;
    • Arribas, Mariano;
    • Wiedmeier-Nutor, Julia E.;
    • Kusne, Yael N.;
    • González Vélez, Miguel;
    • Kosiorek, Heidi E.;
    • Butterfield, Richard J.;
    • Kirsch, Ilan R.;
    • Mikhael, Joseph R.;
    • Stewart, A. Keith;
    • Reeder, Craig;
    • Larsen, Jeremy;
    • Bergsagel, P. Leif;
    • Fonseca, Rafael
    Publication type:
    Article
    12

    Mass Cytometry reveals unique phenotypic patterns associated with subclonal diversity and outcomes in multiple myeloma.

    Published in:
    Blood Cancer Journal, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41408-023-00851-5
    By:
    • Baughn, Linda B.;
    • Jessen, Erik;
    • Sharma, Neeraj;
    • Tang, Hongwei;
    • Smadbeck, James B.;
    • Long, Mark D.;
    • Pearce, Kathryn;
    • Smith, Matthew;
    • Dasari, Surendra;
    • Sachs, Zohar;
    • Linden, Michael A.;
    • Cook, Joselle;
    • Keith Stewart, A.;
    • Chesi, Marta;
    • Mitra, Amit;
    • Leif Bergsagel, P.;
    • Van Ness, Brian;
    • Kumar, Shaji K.
    Publication type:
    Article
    13

    Prognostic value of early bone marrow MRD status in CAR-T therapy for myeloma.

    Published in:
    Blood Cancer Journal, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41408-023-00820-y
    By:
    • Bansal, Radhika;
    • Baksh, Mizba;
    • Larsen, Jeremy T.;
    • Hathcock, Matthew A.;
    • Dingli, David;
    • Stewart, A. Keith;
    • Kapoor, Prashant;
    • Kourelis, Taxiarchis;
    • Hayman, Suzanne R.;
    • Warsame, Rahma M.;
    • Fonseca, Rafael;
    • Bergsagel, P. Leif;
    • Ailawadhi, Sikander;
    • Kumar, Shaji K.;
    • Lin, Yi
    Publication type:
    Article
    14

    Integrated analysis of next generation sequencing minimal residual disease (MRD) and PET scan in transplant eligible myeloma patients.

    Published in:
    Blood Cancer Journal, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41408-023-00794-x
    By:
    • Fonseca, Rodrigo;
    • Arribas, Mariano;
    • Wiedmeier-Nutor, Julia E.;
    • Kusne, Yael N.;
    • González Vélez, Miguel;
    • Kosiorek, Heidi E.;
    • Butterfield, Richard J.;
    • Kirsch, Ilan R.;
    • Mikhael, Joseph R.;
    • Stewart, A. Keith;
    • Reeder, Craig;
    • Larsen, Jeremy;
    • Bergsagel, P. Leif;
    • Fonseca, Rafael
    Publication type:
    Article
    15

    Second symptomatic COVID-19 infections in patients with an underlying monoclonal gammopathy.

    Published in:
    Blood Cancer Journal, 2022, v. 12, n. 11, p. 1, doi. 10.1038/s41408-022-00752-z
    By:
    • Zanwar, Saurabh;
    • Ho, Matthew;
    • Buadi, Francis K.;
    • Ailawadhi, Sikander;
    • Larsen, Jeremy;
    • Bergsagel, Leif;
    • Binder, Moritz;
    • Chanan-Khan, Asher;
    • Dingli, David;
    • Dispenzieri, Angela;
    • Fonseca, Rafael;
    • Gertz, Morie A.;
    • Gonsalves, Wilson;
    • Go, Ronald S.;
    • Hayman, Suzanne;
    • Kapoor, Prashant;
    • Kourelis, Taxiarchis;
    • Lacy, Martha Q.;
    • Leung, Nelson;
    • Lin, Yi
    Publication type:
    Article
    16
    17

    Unique characteristics and outcomes of therapy-related acute lymphoblastic leukemia following treatment for multiple myeloma.

    Published in:
    Blood Cancer Journal, 2022, v. 12, n. 6, p. 1, doi. 10.1038/s41408-022-00680-y
    By:
    • Parrondo, Ricardo D.;
    • Rahman, Zaid Abdel;
    • Heckman, Michael G.;
    • Wieczorek, Mikolaj;
    • Jiang, Liuyan;
    • Alkhateeb, Hassan B.;
    • Litzow, Mark R.;
    • Greipp, Patricia;
    • Sher, Taimur;
    • Bergsagel, Leif;
    • Fonseca, Rafael;
    • Roy, Vivek;
    • Dispenzieri, Angela;
    • Kharfan-Dabaja, Mohamed A.;
    • Murthy, Hemant S.;
    • Ailawadhi, Sikander;
    • Foran, James M.
    Publication type:
    Article
    18
    19

    Mate pair sequencing outperforms fluorescence in situ hybridization in the genomic characterization of multiple myeloma.

    Published in:
    Blood Cancer Journal, 2019, v. 9, n. 12, p. 1, doi. 10.1038/s41408-019-0255-z
    By:
    • Smadbeck, James;
    • Peterson, Jess F.;
    • Pearce, Kathryn E.;
    • Pitel, Beth A.;
    • Figueroa, Andrea Lebron;
    • Timm, Michael;
    • Jevremovic, A. Dragan;
    • Shi, Min;
    • Stewart, A. Keith;
    • Braggio, Esteban;
    • Riggs, Daniel L.;
    • Bergsagel, P. Leif;
    • Vasmatzis, George;
    • Kearney, Hutton M.;
    • Hoppman, Nicole L.;
    • Ketterling, Rhett P.;
    • Kumar, Shaji;
    • Rajkumar, S. Vincent;
    • Greipp, Patricia T.;
    • Baughn, Linda B.
    Publication type:
    Article
    20
    21
    22

    Role of Pirh2 in Mediating the Regulation of p53 and c-Myc.

    Published in:
    PLoS Genetics, 2011, v. 7, n. 11, p. 1, doi. 10.1371/journal.pgen.1002360
    By:
    • Hakem, Anne;
    • Bohgaki, Miyuki;
    • Lemmers, Bénédicte;
    • Tai, Elisabeth;
    • Salmena, Leonardo;
    • Matysiak-Zablocki, Elzbieta;
    • Yong-Sam Jung;
    • Karaskova, Jana;
    • Kaustov, Lilia;
    • Duan, Shili;
    • Madore, Jason;
    • Boutros, Paul;
    • Yi Sheng;
    • Chesi, Marta;
    • Bergsagel, P. Leif;
    • Perez-Ordonez, Bayardo;
    • Mes-Masson, Anne-Marie;
    • Penn, Linda;
    • Squire, Jeremy;
    • Xinbin Chen
    Publication type:
    Article
    23

    Immunosurveillance and therapy of multiple myeloma are CD226 dependent.

    Published in:
    2015
    By:
    • Guillerey, Camille;
    • Ferrari de Andrade, Lucas;
    • Vuckovic, Slavica;
    • Miles, Kim;
    • Ngiow, Shin Foong;
    • Yong, Michelle C R;
    • Teng, Michele W L;
    • Colonna, Marco;
    • Ritchie, David S;
    • Chesi, Martha;
    • Bergsagel, P Leif;
    • Hill, Geoffrey R;
    • Smyth, Mark J;
    • Martinet, Ludovic;
    • Chesi, Marta
    Publication type:
    journal article
    24

    Immunosurveillance and therapy of multiple myeloma areCD226 dependent.

    Published in:
    Journal of Clinical Investigation, 2015, v. 125, n. 5, p. 2077, doi. 10.1172/JCI77181
    By:
    • Guillerey, Camille;
    • Ferrari de Andrade, Lucas;
    • Vuckovic, Slavica;
    • Miles, Kim;
    • Shin Foong Ngiow;
    • Yong, Michelle C. R.;
    • Teng, Michele W. L.;
    • Colonna, Marco;
    • Ritchie, David S.;
    • Chesi, Martha;
    • Bergsagel, P. Leif;
    • Hill, Geoffrey R.;
    • Smyth, MarkJ.;
    • Martinet, Ludovic
    Publication type:
    Article
    25
    26
    27

    P871: IDECABTAGENE VICLEUCEL (IDE-CEL) IN PATIENTS WITH AN INADEQUATE RESPONSE TO FRONTLINE AUTOLOGOUS STEM CELL TRANSPLANTATION (ASCT): RESULTS FROM KARMMA-2 COHORT 2C.

    Published in:
    2023
    By:
    • Alsina, Melissa;
    • Dhodapkar, Madhav;
    • Berdeja, Jesus;
    • Patel, Krina;
    • Richard, Shambavi;
    • Vij, Ravi;
    • Leleu, Xavier;
    • Egan, Daniel;
    • Leif Bergsagel, P.;
    • Ran, Reshef;
    • Usmani, Saad Z;
    • Truppel-Hartmann, Anna;
    • Basudhar, Debashree;
    • Thompson, Ethan;
    • Zheng, Xirong;
    • Zhong, Xiaobo;
    • Greggio, Chiara;
    • Popa Mckiver, Mihaela;
    • Carrasco Alfonso, Marlene;
    • Siegel, David
    Publication type:
    Abstract
    28
    29

    A phase 2 study of rituximab, cyclophosphamide, bortezomib and dexamethasone (R-CyBorD) in relapsed low grade and mantle cell lymphoma.

    Published in:
    Leukemia & Lymphoma, 2018, v. 59, n. 9, p. 2128, doi. 10.1080/10428194.2017.1416368
    By:
    • Sonbol, Mohamad Bassam;
    • Hilal, Talal;
    • Rosenthal, Allison C.;
    • Leis, Jose F.;
    • Northfelt, Donald W.;
    • Bergsagel, Peter Leif;
    • Reeder, Craig B.;
    • Dueck, Amylou C.;
    • Kosiorek, Heidi E.;
    • Ginos, Brenda F.;
    • Conley, Christopher R.;
    • Gano, Katherine M.;
    • Nichols, Craig S.;
    • Johnston, Patrick B.;
    • Habermann, Thomas M.;
    • Inwards, David J.;
    • Witzig, Thomas E.;
    • Ansell, Stephen M.
    Publication type:
    Article
    30
    31
    32

    A comparison of lenalidomide/dexamethasone versus cyclophosphamide/lenalidomide/dexamethasone versus cyclophosphamide/bortezomib/dexamethasone in newly diagnosed multiple myeloma.

    Published in:
    British Journal of Haematology, 2012, v. 156, n. 3, p. 326, doi. 10.1111/j.1365-2141.2011.08949.x
    By:
    • Khan, Meaghan L.;
    • Reeder, Craig B.;
    • Kumar, Shaji K.;
    • Lacy, Marthy Q.;
    • Reece, Donna E.;
    • Dispenzieri, Angela;
    • Gertz, Morie A.;
    • Greipp, Phillip;
    • Hayman, Suzanne;
    • Zeldenhurst, Steven;
    • Dingli, David;
    • Lust, John;
    • Russell, Stephen;
    • Laumann, Kristina M.;
    • Mikhael, Joseph R.;
    • Leif Bergsagel, P.;
    • Fonseca, Rafael;
    • Vincent Rajkumar, S.;
    • Keith Stewart, A.
    Publication type:
    Article
    33
    34

    Modifications of the mouse bone marrow microenvironment favor angiogenesis and correlate with disease progression from asymptomatic to symptomatic multiple myeloma.

    Published in:
    OncoImmunology, 2015, v. 4, n. 6, p. 0, doi. 10.1080/2162402X.2015.1008850
    By:
    • Calcinotto, Arianna;
    • Ponzoni, Maurilio;
    • Ria, Roberto;
    • Grioni, Matteo;
    • Cattaneo, Elena;
    • Villa, Isabella;
    • Bertilaccio, Maria Teresa Sabrina;
    • Chesi, Marta;
    • Rubinacci, Alessandro;
    • Tonon, Giovanni;
    • Bergsagel, P Leif;
    • Vacca, Angelo;
    • Bellone, Matteo
    Publication type:
    Article
    35

    Che-1-induced inhibition of mTOR pathway enables stress-induced autophagy.

    Published in:
    EMBO Journal, 2015, v. 34, n. 9, p. 1214, doi. 10.15252/embj.201489920
    By:
    • Desantis, Agata;
    • Bruno, Tiziana;
    • Catena, Valeria;
    • De Nicola, Francesca;
    • Goeman, Frauke;
    • Iezzi, Simona;
    • Sorino, Cristina;
    • Ponzoni, Maurilio;
    • Bossi, Gianluca;
    • Federico, Vincenzo;
    • La Rosa, Francesca;
    • Ricciardi, Maria Rosaria;
    • Lesma, Elena;
    • De Meo, Paolo D'Onorio;
    • Castrignanò, Tiziana;
    • Petrucci, Maria Teresa;
    • Pisani, Francesco;
    • Chesi, Marta;
    • Bergsagel, P Leif;
    • Floridi, Aristide
    Publication type:
    Article
    36
    37
    38
    39

    Single-Cell Proteomics and Tumor RNAseq Identify Novel Pathways Associated With Clofazimine Sensitivity in PI- and IMiD- Resistant Myeloma, and Putative Stem-Like Cells.

    Published in:
    Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.842200
    By:
    • Kumar, Harish;
    • Mazumder, Suman;
    • Sharma, Neeraj;
    • Chakravarti, Sayak;
    • Long, Mark D.;
    • Meurice, Nathalie;
    • Petit, Joachim;
    • Liu, Song;
    • Chesi, Marta;
    • Sanyal, Sabyasachi;
    • Stewart, A. Keith;
    • Kumar, Shaji;
    • Bergsagel, Leif;
    • Rajkumar, S. Vincent;
    • Baughn, Linda B.;
    • Van Ness, Brian G.;
    • Mitra, Amit Kumar
    Publication type:
    Article
    40
    41
    42
    43
    44
    45
    46
    47

    Impact of belantamab mafodotin‐induced ocular toxicity on outcomes of patients with advanced multiple myeloma.

    Published in:
    British Journal of Haematology, 2022, v. 199, n. 1, p. 95, doi. 10.1111/bjh.18298
    By:
    • Abeykoon, Jithma P.;
    • Vaxman, Julia;
    • Patel, Sanjay V.;
    • Kumar, Shaji;
    • Malave, Gabriella C.;
    • Young, Kimberly S.;
    • Ailawadhi, Sikander;
    • Larsen, Jeremy T.;
    • Dispenzieri, Angela;
    • Muchtar, Eli;
    • Gonsalves, Wilson I.;
    • Kourelis, Taxiarchis;
    • Leung, Nelson;
    • Warsame, Rahma;
    • Go, Ronald S.;
    • Bergsagel, Leif;
    • Lacy, Martha Q.;
    • Rajkumar, S. Vincent;
    • Gertz, Morie A.;
    • Kapoor, Prashant
    Publication type:
    Article
    48
    49
    50